Please select the option that best describes you:
Topics:
Hematologic Malignancies • Radiation Oncology • Medical Oncology • Lymphoma • Internal Medicine • Hematology
What is your preferred approach to a patient with newly diagnosed primary mediastinal B-cell lymphoma in the upfront setting?
Specifically, is there still a role for dd RCHOP followed by ICE, or do you recommend DA-R-EPOCH for all patients?
Answer from: Medical Oncologist at Academic Institution
I recommend DA-R-EPOCH in almost all patients. For the rare patients with stage 3-4 disease, I consider RCHOPx4 followed by ICE (unpublished data from Memorial Sloan Kettering).
Sign in or Register to read more